Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
While multi-drug treatments can be effective, evidence supporting their combined use remains limited
Headaches reported in clinical trials were generally classified as mild to moderate in severity, and discontinuation of therapy due to headaches alone was uncommon
No filters on time of publication were applied
Tirzepatide (Mounjaro, Zepbound) may be more effective than injectable semaglutide (Ozempic, Wegovy)
goal 23 semisoft stools per day) plus albumin (1.5 g/kg/day) or lactulose alone, and treatment was continued until recovery of HE or for a maximum of 10 days
MH: Bless your heart
US$ 24.97
US$ 23.19
US$ 23.87
US$ 22.95
